Fig. 1From: L-theanine prevents progression of nonalcoholic hepatic steatosis by regulating hepatocyte lipid metabolic pathways via the CaMKKβ-AMPK signaling pathwayL-theanine alleviates hepatic steatosis in OA induced HepG2 and AML12 cells. HepG2 and AML12 cells were treated with 500 μM OA for 24 h with or without pretreated L-theanine for 2 h. A Representative Oil Red O staining of HepG2 and AML12 cells. Scale bar: 50 μm (40 ×). Intracellular TG levels in HepG2 (B) and AML12 (C) cells. Values are expressed as mean ± SEM of three independent experiments. ***p < 0.001, ****p < 0.0001 versus control group; #p < 0.05, ##p < 0.01 versus OA group. LT, L-theanineBack to article page